logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Durvalumab/TremelimumabGrade 3 maculopapular rash and lack of efficacy: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2024年 / 2031卷 / 1期
关键词:
D O I:
10.1007/s40278-024-69431-x
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:151 / 151
相关论文
共 50 条
  • [11] CefiximeErythematous maculopapular rash: case report
    Reactions Weekly, 2022, 1914 (1) : 149 - 149
  • [12] CotrimoxazoleGeneralised maculopapular rash: case report
    Reactions Weekly, 2015, 1579 (1) : 127 - 127
  • [13] DasatinibMalaise and maculopapular rash: case report
    Reactions Weekly, 2015, 1542 (1) : 90 - 90
  • [14] SulfadiazinePruritic maculopapular rash: case report
    Reactions Weekly, 2021, 1879 (1) : 333 - 333
  • [15] RopivacaineExuberant maculopapular rash: case report
    Reactions Weekly, 2015, 1575 (1) : 189 - 189
  • [16] EphedrineGeneralised maculopapular rash: case report
    Reactions Weekly, 2018, 1719 (1) : 94 - 94
  • [17] AntibacterialsNocardia nova septic pulmonary emboli, endocarditis, diffuse maculopapular drug rash and lack of efficacy: case report
    Reactions Weekly, 2021, 1867 (1) : 38 - 38
  • [18] SorafenibHypertension and maculopapular rash: case report
    Reactions Weekly, 2016, 1613 (1) : 251 - 251
  • [19] CotrimoxazoleErythematous and maculopapular rash: case report
    Reactions Weekly, 2019, 1762 (1) : 122 - 122
  • [20] FingolimodTransient maculopapular rash: case report
    Reactions Weekly, 2017, 1644 (1) : 132 - 132
← 12345 →